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Abstract 
a,-Macroglobuhn receptor/low density hpoprotem receptor-related protein (cc,M-RILRP) IS a multi-functional cell-surface receptor that has been 
tmphcated m diverse physiologic processes In normal human brain, a,M-R/LRP IS expressed prmclpally by pyramldal neurons with locahzation 
to cell bodies and proximal processes By contrast, a,M-R/LRP 1s not present m either the cell bodies or processes of most normal macrogha (mcludmg 
astrocytes) In this mvestlgatlon, we studied the expression of a,M-FULRP m the brain, followmg tissue InJury or neoplastic transformation, by 
lmmunohistochemlstry Significantly increased a,M-R/LRP lmmunoreactivlty was ldentlfied m reactive astrocytes, mdlcatmg that expression of this 
receptor is regulated m viva m response to brain injury a2M-R/LRP lmmunoreactivlty was also detected m ghal cell tumors. this finding 1s novel 
since malignant ransformation 1s typically thought to turn off expression of this receptor 
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1. Introduction 
ol,-Macroglobuhn receptor/low-density hpoprotem re- 
ceptor-related protem (a,M-RILRP) 1s a multl-func- 
tlonal plasma membrane receptor which has been lmph- 
cated m cellular hpoprotem metabolism, cell-surface 
trafficking of plasmmogen activators and then mhlb- 
ltors, modulation of growth factor responses, and Pseu- 
domonas exotoxm A clearance [l-6] a,M-RILRP 1s syn- 
thesized as a 600 kDa precursor protein which undergoes 
post-translational processing mto 5 15-kDa and 85-kDa 
subunits [7,8]. The 5 15-kDa subunit confers hgand bmd- 
mg activity and 1s entirely extracellular The 85-kDa sub- 
unit has a transmembrane domam that anchors the large 
subunit to the cell surface by a non-covalent interaction 
[8,9] a,M-RILRP and Its mRNA are distributed 
through numerous human tissues [7,10], however, the 
cellular distribution m human brain 1s selective Im- 
munoreactlvlty 1s restricted almost exclusively to neu- 
rons, prmclpally of the pyramidal type m the cerebral 
cortex, subcortlcal gray matter, and cerebellum [lO,l 1] 
Although a,M-RILRP 1s not normally expressed by 
most gha, lmmunoreactlvlty is detected m a highly local- 
ized perlvascular zone which corresponds to the dlstnbu- 
tlon of astrocytic foot processes. Expression of a,M-RI 
LRP m this region suggests a role for the receptor m the 
function of the blood-brain barrier 
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Expression of a,M-RILRP IS regulated m vitro by 
cytokmes and mediators of mflammatlon In macro- 
phages, cx,M-R/LRP 1s up-regulated by colony stlmulat- 
mg factor-l and down-regulated by interferon-y and 
bacterial hpopolysaccharlde [ 12,131 Based on work with 
fibroblasts m culture, Van Leuven et al [14] suggested 
that cancer cells may express greatly decreased levels of 
a,M- R/LRP. More recently, we demonstrated that &,M- 
R/ LRP 1s decreased or absent m hepatocellular carcmo- 
mas, as determined by lmmunohlstochemlstry [15] 
Followmg brain injury or after neoplastlc transforma- 
tion, astrocytes undergo profound phenotyplc changes, 
associated with increased prohferatlon and an aug- 
mented capacity for tissue mvaslon The purpose of the 
present mvestlgatlon was to determine whether brain 
qury or ghal neoplastlc transformation 1s associated 
with altered ol,M-R/LRP expression 
2. Materials and methods 
2 I Materials 
Fifty-seven ghoma specimens from archives of the Umverslty of 
Virgmla Health Sciences Center were exammed The tumors were clas- 
sified accordmg to the World Health Orgamzatlon (WHO) crltena [16] 
Hlstopathological exammatlon revealed 4 low-grade astrocytomas, 2
gemlstocytic astrocytomas, 11 anaplastic astrocytomas, I3 ghoblasto- 
mas multiforme, 2 gliosarcomas, 13 pilocytic astrocytomas, 1pleomor- 
phic xanthoastrocytoma, 1 optic ghoma, 3 ohgodendroghomas, and 7 
ependymomas Reactive (non-neoplastic) astrocytes were studied m 5 
specimens with acute and chronic infarcts and m the tissue adjacent o 
tumors 
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2 2 Immunohutochemzstry 
Monoclonal antlbody 8Gl dlrected against he a,M-R/LRP SlS-kDa 
cham was kmdly provided by Dr Dudley K Stnckland (Amencan Red 
Cross, Rockvdle, MD) 8Gl was incubated with formahn-fixed, de- 
paraffimzed sectlons for 15-18 h at 4°C The primary antibody was 
detected usmg the avldm-blotm lmmunoperoxldase technique [l l] 
Normal non-immune serum was substituted for primary antibody as 
a negative control Sections of normal human liver were treated m 
parallel to provide positive controls 
3. Results and discussion 
In contrast with quiescent astrocytes m normal brain, 
activated astrocytes m the gray and white matter were 
consistently mrmunoreactive for a,M-RILRP The pat- 
tern of immunoreactivity varied from predommantly 
permuclear, punctate accumulations, to a more diffuse 
cytoplasmic distribution The first pattern (Fig 1, arrow- 
heads) was highly suggestive of an mtracytoplasmic dis- 
tribution while the diffuse form (Fig 1, inset) could re- 
flect a combmation of both surface and cytoplasmic lo- 
calization The cytoarchitectural distribution of a,M-RI 
LRP m reactive astrocytes was clearly different from the 
restricted pattern of mmmnoreactivity m perivascular 
astrocytic processes, reported previously [l 11. Activated 
astrocytes were the only reactive ghal cells with increased 
a,M-R/LRP Myelm-forming ohgodendrocytes and 
ependymal cells, which lined the ventricles m zones con- 
tiguous with injured brain, did not show a,M-RILRP 
immunoreactivity. 
Neoplastic transformation of macroghal cells resulted 
m increased expression of a,M-RILRP antigen, irre- 
gardless of cell type (ie astrocytic, ohgodendroghal or 
ependymal) (Table 1); however, the level and cy- 
toarchitectural distribution of a,M-RILRP m the differ- 
ent tumors was variable (Table 2). Astrocytomas which 
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Table 1 
a,M-R/LRP lmmunohlstochemlstrv m ghomas 
Tumor Cases (positive/total) 
Astrocytoma 414 
Gemistocytic astrocytoma 212 
Anaplastlc astrocytoma 11111 
Ghoblastoma multlforme 12113 
Pleomorphlc xanthoastrocytoma l/l 
Pllocytic astrocytoma 12113 
Optic ghoma l/l 
Ohgodendroghoma 313 
Ependymoma Ill 
diffusely invade surrounding brain are shown m Fig 
2A-C In many of the tumor cells, a,M-RILRP im- 
munoreactivity was conspicuously localized m the cyto- 
plasm as punctate, permuclear accumulations (panels A 
and C). Other tumor cells with larger amounts of cyto- 
plasm showed more diffuse mununoreactivity (Fig 2B 
and 2C inset) In contrast to the invasive astrocytomas, 
pilocytic astrocytomas, which have limited capacity to 
invade, expressed a,M-RILRP primarily m cell processes 
(Fig 2D) 
Most neoplastic ohgodendroghal cells (Fig 3) and 
ependymal cells (not shown) expressed a,M-RILRP, m 
contrast with then non-malignant (normal and reactive) 
counterparts, which were nnmunonegative The pattern 
of mmmnoreactivity m the ohgodendroghomas varied 
Most cells expressed a,M-R/LRP m a punctate, permu- 
clear pattern, similar to that observed with reactive and 
neoplastic astrocytes (panel A) Other cells demonstrated 
a,M-RILRP nnmunopositivity m a more diffuse pattern 
(panel B); however, this distribution was not common 
The results reported m this mvestigation provide sharp 
Fig 1 Locahzatlon of a,M-R/LRP m a brain infarct Reactive astrocytes on the penphery of the lesion (left) demonstrated cytoplasmlc a,M-RILRP 
lmmunoreactlvity mboth a punctate (small astrocytes, arrowheads) and diffuse (inset gemlstocytlc astrocytes, upper, and fibnllary astrocyte, arrow) 
pattern Fibnllary astrocytes with promment stammg m cellular processes were present m small numbers (inset, arrow) [Monoclonal antibody 8Gl 
lmmunoperoxldase, DAB with light hematoxyhn counterstam, x 300, x 600 mset ] 
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Table 2 
Pattern of a,M-R/LRP lmmunoreactlvlty m ghal cells 
Cytoplasmlc dlstnbutlon 
Reactive astrocytes punctate (clrcumscnbed) > diffuse 
Neoplastlc macrogha punctate (arcumscnbed) > diffuse 
Cellular processes 
Reactive astrocytes rare 
Infiltrating astrocytomas rare 
Clrcumscnbed astrocytomas common 
Ohgodendroghomas rare 
Ependymomas rare 
Cell surface 
Reactive astrocytes 
Astrocytomas 
Ohgodendroghomas 
Ependymomas 
none 
present 
present 
none 
contrast with our previous study of normal human brain 
[l l] Expression of a,M-R/LRP m reactive and trans- 
formed astrocytes suggests that these cells synthesize 
a,M-R/LRP in response to physrologrc signals in VIVO. 
The predominant mtracytoplasmtc localization of a,M- 
R/LRP in reactive and neoplastic macrogha was surpris- 
mg since a,M-R/LRP is a plasma membrane receptor. 
Moestrup et al. [17] reported a stmtlar finding in their 
analysts of fibroblasts and attributed the mtracytoplas- 
mic distrrbutton of a,M-R/LRP to intracellular vesicles 
m the receptor recycling pathway. 
The function of a,M-R/LRP in normal brain is stall 
unknown, however, protemases, proteinase inhibitors 
and cytokmes are important effecters of ghal-neuronal 
cell interactions. Based on its ability to bmd diverse h- 
gands (some of which are carriers of other macromole- 
Fig 2 Locahzatlon of &M-R/L.RP m astrocytlc tumors (A-C) &M-R/LRP nnmunoreactlvlty was detected m all grades of diffusely mfiltratmg 
astrocytomas (A) a,M-RILRP lmmunoreactlvlty m low-grade astrocytomas was locahzed m the cytoplasm as pun&ate stammg (arrowheads) m the 
pennuclear egon (x 600) (B) Tumor cells with increased cytoplasmlc SW. (gemlstoqtlc astrocytes) usually had a more diffuse pattern of stammg 
Note that the fine fibnllary processes (arrowheads) of the tumor cells are not labelled (x 600) (C)Cells m ghoblastoma multlforme also demonstrated 
a punctate pattern of lmmunostammg for a,M-R/LRP (arrowheads) while the mcreased cytoplasm of @ant, multmucleated cells was more diffusely 
lmmunoreactive (X 300, x 600 Inset) (D) Pllocytlc astrocytomas demonstrated a stnkmg difference of &,M-R/LRP dlstnbutlon, m contrast to the 
diffusely mvaslve astrocytlc tumors, with lmmunoreactlvlty locahzed only to cell processes Note the fine particulate pattern of the stammg m the 
cellular processes (x 600) (Monoclonal antibody 8Gl lmmunoperoxldase, DAB Hrlth hematoxyhn counterstam) 
Fig 3 Locahzatlon of a,M-RILRP m ohgodendroghomas (A) a,M-RI 
LRP lmmunoreactlvlty was conspicuously localized as punctate, per- 
muclear accumulations m the scant cytoplasm (B) In focal areas of the 
same tumor, blunt cellular processes and plasma membrane were also 
hlghhghted by the lmmunostdmmg (x 600) (8Gl lmmunoperoxldase ) 
cules), a,M-RILRP may function m the transfer of critl- 
cal effecters between cells m the bram For example, 
cytokmes, such as transforming growth factor-/?1 (TGF- 
/?l) and platelet-derived growth factor (PDGF), bmd to 
activated azM which 1s a hgand for a,M-RILRP Since 
cytokme bmdmg does not mhlblt the mteractlon of a,M 
with its receptor, these complexes can be targeted to cells 
which express a,M-RILRP [5,18] In the brain, PDGF 1s 
important m ghogenesls [ 191 PDGF also supports prohf- 
eratlon of reactive astrocytes followmg brain mJury [20] 
PDGF and TGF-B mfluence the growth of malignant 
ghomas [21,22] Smce a,M IS present m developmg brain 
[23] and m adult bram durmg subacute responses to 
mlury and chronic degenerative states [24,25], a,M may 
influence the traffickmg of TGF-P and PDGF between 
cells m the brain The ultimate delivery of a,M-TGF-j? 
or a,M-PDGF complex to a particular bram cell de- 
pends on expression of a,M-RILRP Disease processes 
which increase a,M-RILRP expression m ghal cells 
might facilitate ol,M-targetmg of TGF-/3 and PDGF to 
these cells 
Bmdmg of hgands to cx,M-RILRP results m receptor 
clustering m clathrm-coated pits and rapid clearance of 
the receptor-hgand complexes from the cell surface by 
endocytosls [26] The hgands are transferred to lyso- 
somes while the a,M-RILRP typically recycles to the cell 
surface [27] Although all types of ghomas exhlblted 
a,M-RILRP immunoreactlvlty, the more mvaslve astro- 
cytomas demonstrated apredommantly cytoplasmlc pat- 
tern of a,M-R/LRP stammg while the less mvaslve pllo- 
cytlc astrocytomas expressed a,M-RILRP primarily m 
cell processes Pllocytlc astrocytomas express high levels 
of protemase mhlbltors compared with other ghal cell 
neoplasms [28] Whether expression of protemase mhlb- 
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ltors and a,M-RILRP supports the non-mvaslve pheno- 
type of the pllocytlc astrocytoma 1s a topic for future 
investigation 
In summary, the present study has demonstrated that 
expression of a,M-RILRP is regulated m ghal cells m 
vlvo Regulated expression and selective cellular locah- 
zatlon of a,M-RILRP m reactive and neoplastlc gha sug- 
gests a role for this receptor m ghal cell function 
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